A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV
Journal
Vaccines
Journal Volume
11
Journal Issue
1
Date Issued
2023-01
Author(s)
Cheng, Shu-Hsing
Lien, Chia En
Cheng, Chien-Yu
Lo, Ching-Lung
Ko, Wen-Chien
Chen, Yen-Hsu
Huang, Ching-Tai
Chang, Hsiao-Ting
Hwang, Shinn-Jang
Wang, Ning-Chi
Liu, Ming-Che
Lee, Yu-Lin
Tai, I-Chen
Estrada, Josue Antonio Garcia
Lin, Tzou-Yien
Lee, Wen-Sen
Abstract
This study aimed to assess the safety and immunogenicity of MVC-COV1901, a recombinant COVID-19 protein vaccine, containing S-2P protein adjuvanted with CpG 1018 and aluminum hydroxide, for people living with HIV (PWH).
Subjects
CD4/CD8 ratio; COVID-19 vaccine; CpG 1018; HIV; S-2P protein; immunogenicity
SDGs
Publisher
MDPI
Type
journal article
